Clinical Trials Browser

Phase 1 × Recurrence × zanubrutinib × Clear all

NCT06824701 2025-12-03

TARZAN

Phase 1 Recruiting

Recurrence, Lymphoma, B-Cell

NCT02795182 2022-07-01

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

Phase 1 Completed

75 enrolled 17 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence